Technical Analysis for EIGR - Eiger BioPharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 9.81 -1.51% -0.15
EIGR closed down 1.09 percent on Thursday, February 27, 2020, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Mar 12
*** please verify all earnings dates ***

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical EIGR trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction -1.51%
Doji - Bullish? Reversal -1.51%
Lower Bollinger Band Walk Weakness -1.51%
Multiple of Ten Bearish Other -1.51%
Below Lower BB Weakness -1.51%
Down 3 Days in a Row Weakness -1.51%
Down 4 Days in a Row Weakness -1.51%
Lower Bollinger Band Touch Weakness -1.51%
Oversold Stochastic Weakness -1.51%
Jack-in-the-Box Bearish Bearish Swing Setup -2.58%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Eiger BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops a portfolio of late-stage drugs for orphan diseases. It offers Sarasar, which is used for the treatment of hepatitis delta; Exendin that is used for the treatment of hypoglycemia; and Bestatin, which is used for the treatment of pulmonary arterial hypertension and lymphedema. Eiger BioPharmaceuticals, Inc. was founded in 2008 and is based in Palo Alto, California.
Biotechnology Biopharmaceutical Life Sciences Pharmaceutical Industry Pharmacy Specialty Drugs Pulmonary Arterial Hypertension Hepatitis Pulmonary Hypertension Orphan Diseases Hypoglycemia

Is EIGR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.82
52 Week Low 9.38
Average Volume 280,462
200-Day Moving Average 11.51
50-Day Moving Average 13.07
20-Day Moving Average 11.65
10-Day Moving Average 11.20
Average True Range 0.69
ADX 33.71
+DI 7.73
-DI 36.79
Chandelier Exit (Long, 3 ATRs ) 11.11
Chandelier Exit (Short, 3 ATRs ) 11.58
Upper Bollinger Band 13.10
Lower Bollinger Band 10.20
Percent B (%b) -0.08
BandWidth 24.88
MACD Line -0.72
MACD Signal Line -0.56
MACD Histogram -0.1612
Fundamentals Value
Market Cap 83.34 Million
Num Shares 8.37 Million
EPS -5.68
Price-to-Earnings (P/E) Ratio -1.75
Price-to-Sales 0.00
Price-to-Book 4.37
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.75
Resistance 3 (R3) 11.79 11.24 11.45
Resistance 2 (R2) 11.24 10.79 11.22 11.35
Resistance 1 (R1) 10.60 10.50 10.92 10.56 11.25
Pivot Point 10.05 10.05 10.21 10.03 10.05
Support 1 (S1) 9.41 9.60 9.73 9.37 8.67
Support 2 (S2) 8.86 9.31 8.84 8.57
Support 3 (S3) 8.22 8.86 8.47
Support 4 (S4) 8.18